swiss drugmaker novartis has announced 565bn euros 74bn Â£39bn of purchases to make its sandoz unit the worlds biggest generic drug producernovartis said that it would be able to make cost savings of about 200m a year following the acquisitionsnovartis said that it would merge a number of departments adding that there may be job cutsthe deal will see novartis sandoz business overtake israels teva pharmaceuticals as the worlds biggest maker of genericsnovartis which last month forecast record sales for 2005 said it had bought all of germanys hexalnovartis shares rose 1 to 5785 swiss francs in early trading
